Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...

Modified-Release Drug Delivery Systems: Overview

Modified-Release Drug Delivery Systems: Overview

Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...

Production of Pharmaceuticals

Production of Pharmaceuticals

Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...

Modified-Release Drug Delivery Systems: Rate-Programmed II

Modified-Release Drug Delivery Systems: Rate-Programmed II

Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...

Drug Delivery: Overview

Drug Delivery: Overview

The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...

Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices

Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices

Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same journal

Naturally derived excipients in injectable nanomedicines: a systematic review of pharmacokinetic performance, regulatory readiness, and future quality by design perspectives.

Therapeutic delivery·2026

Same journal

Flavonoid nanoformulations for cutaneous administration: overcoming delivery barriers for targeted therapeutics and bioavailability enhancement.

Therapeutic delivery·2026

Same journal

Optimization of nanoemulsion formulations of <i>Piper sarmentosum</i> for topical application in skin cancer.

Therapeutic delivery·2026

Same journal

An evaluation of aripiprazole long-acting injectable monthly and bimonthly in the maintenance treatment of bipolar I disorder.

Therapeutic delivery·2026

Same journal

A decision-support workflow for the selection of mathematical models in drug dissolution and release studies.

Therapeutic delivery·2026

Same journal

Ternary co-encapsulation in electrospun PVA fibers: release kinetics and mechanisms.

Therapeutic delivery·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 19, 2026

Process Development for the Spray-Drying of Probiotic Bacteria and Evaluation of the Product Quality

Process Development for the Spray-Drying of Probiotic Bacteria and Evaluation of the Product Quality

Published on: April 7, 2023

Pharmaceutical spray drying: solid-dose process technology platform for the 21st century.

Herman E Snyder¹

¹PARSEC Solutions LLC, Purdue Technology Center, 1281 Win Hentschel Boulevard, West Lafayette, IN 47906, USA. hsnyder@parsecsolns.com

Therapeutic Delivery

|August 21, 2012

Summary

This summary is machine-generated.

Spray drying technology offers precise control over pharmaceutical solid-dosage particle properties for advanced drug delivery and stability. This scalable process enables high-throughput manufacturing of active pharmaceutical ingredients with tailored characteristics.

More Related Videos

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

Disposable Dosators for Pulmonary Insufflation of Therapeutic Agents to Small Animals

Disposable Dosators for Pulmonary Insufflation of Therapeutic Agents to Small Animals

Published on: March 30, 2017

Related Experiment Videos

Last Updated: May 19, 2026

Process Development for the Spray-Drying of Probiotic Bacteria and Evaluation of the Product Quality

Process Development for the Spray-Drying of Probiotic Bacteria and Evaluation of the Product Quality

Published on: April 7, 2023

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

Disposable Dosators for Pulmonary Insufflation of Therapeutic Agents to Small Animals

Disposable Dosators for Pulmonary Insufflation of Therapeutic Agents to Small Animals

Published on: March 30, 2017

Area of Science:

Pharmaceutical Technology
Materials Science
Chemical Engineering

Background:

Growing demand for precise control of solid-dosage particle properties in pharmaceuticals.
Emerging pharmaceutical applications benefiting from spray drying include novel drug delivery, enhancing solubility, and improving stability.
Expanding pharmaceutical uses of spray drying beyond excipient production and solvent removal.

Purpose of the Study:

To review the fundamentals of spray-drying technology for pharmaceutical applications.
To provide perspective on the internal mechanics of spray drying.
To highlight the role of spray drying in continuous manufacturing of precision powder properties.

Main Methods:

Review of spray-drying technology fundamentals.
Analysis of internal process mechanics.
Consideration of liquid and solid formulation properties.

Main Results:

Spray drying enables precise control over particle properties for pharmaceutical solid dosage forms.
The technology facilitates high-throughput, continuous manufacturing.
It addresses challenges in drug delivery, solubility, and stability.

Conclusions:

Spray drying is a versatile and scalable technology for producing pharmaceutical particles with tailored properties.
Understanding the process mechanics is key to optimizing powder characteristics.
It supports advanced pharmaceutical manufacturing and product development.